Delivery Order SPE2DF26D0007-SPE2D626F7V06

<p>The Defense Logistics Agency Medical Supply Chain issued a $3,979.80 delivery order to Abbott Rapid DX North America LLC on March 4, 2026, for BinaxNOW COVID-19 antigen test cards, with an ultimate completion date of March 25, 2026.</p> <p>Place of performance is Lake Mary, FL. The order carries a fixed-price structure with economic price adjustment. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Rapid DX North America LLC on March 9, 2026, with a ceiling value of $3,618.00 for BinaxNOW nucleocapsid protein COVID-19 antigen test cards. The order carries a fixed-price structure with economic price adjustment and is scheduled for completion by March 25, 2026. Place of performance is Lake Mary, FL.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $2,400 delivery order to Abbott Rapid DX North America LLC on March 5, 2026, for COVID-19 test kits. The order has a fixed-price structure with economic price adjustment and an ultimate completion date of March 16, 2026.</p> <p>Place of performance is Lake Mary, FL 32746. No set-aside was used for this order.</p>

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order for BinaxNOW COVID-19 antigen test cards valued at $1,005.05 on December 18, 2025, with an ultimate completion date of January 12, 2026. The contract is fixed-price with economic price adjustment pricing and carries no set-aside designation. Performance will take place in Lake Mary, Florida. Funding originates from the Defense Logistics Agency's Medical Supply Chain, a defense-focused...

The Defense Logistics Agency Medical Supply Chain issued a $6,000 delivery order to Abbott Rapid DX North America LLC on March 2, 2026, for COVID-19 diagnostic test kits under a fixed-price contract with economic price adjustment. Place of performance is Lake Mary, FL. The order is due for completion on March 11, 2026. Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., supplies point-of-care testing devices and rapid antigen tests to federal healthcare agencies, with...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on December 4, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,005.05. This fixed-price delivery order with economic price adjustment will be performed in Lake Mary, Florida, and is funded through the Defense Logistics Agency's Medical Supply Chain division. The contract carries no small business set-aside designation and represents an ongoing procurement of...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order for BinaxNOW COVID-19 Antigen Test Cards with a ceiling value of $2,010.10. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of February 10, 2026. This delivery order was issued without set-aside designation on January 20, 2026, and will be performed in Lake Mary, Florida. Funding originates from...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order valued at $6,030.30 for BinaxNOW COVID-19 antigen test cards on July 31, 2025, with an ultimate completion date of August 21, 2025. The contract, which carries a fixed-price structure with economic price adjustment provisions, was awarded without a set-aside designation, indicating full and open competition. Performance will be executed in Lockhart, Florida, and the contract is funded through...

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Rapid DX North America LLC on February 3, 2026, for COVID-19 rapid diagnostic test kits with a ceiling value of $3,000.</p> <p>Place of performance is Lake Mary, FL. The order is priced as fixed price with economic price adjustment and carries an ultimate completion date of February 12, 2026. No set-aside was used for this award.</p>

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,608.08 for BinaxNOW COVID-19 antigen test cards. The contract, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries a fixed-price structure with economic price adjustment provisions. Funding originates from the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies...